No Data
No Data
Vivos Therapeutics Files to Sell 854,332 Shares of Common Stock for Holders
Revenues Tell The Story For Vivos Therapeutics, Inc. (NASDAQ:VVOS) As Its Stock Soars 26%
Vivos Therapeutics Launches $3.5 Million Registered Direct Offering
Vivos Therapeutics Announces Funding Boost | NASDAQ:VVOS
Express News | Vivos Therapeutics Announces $3.5 Million Registered Direct Offering Priced at-the-Market Under Nasdaq Rules
All You Need to Know About Vivos Therapeutics (VVOS) Rating Upgrade to Buy